The immune microenvironment characterisation and dynamics in hormone receptor-positive breast cancer before and after neoadjuvant endocrine therapy
Bron
Cancer Medicine - ISSN 2045-7634-12:17 (2023) p. 17901-17913
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer : updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
Bron
The lancet : international edition - ISSN 0140-6736-401:10371 (2023) p. 105-117
Health-related quality of life in older patients with HER plus metastatic breast cancer : comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial
Bron
Journal of Geriatric Oncology - ISSN 1879-4068-13:5 (2022) p. 582-593
Homologous recombination repair deficiency (HRD) testing in newly diagnosed advanced-stage epithelial ovarian cancer : a Belgian expert opinion
Bron
Facts, views & vision in obgyn : issues in obstetrics, gynaecology and reproductive health - ISSN 2032-0418-14:2 (2022) p. 111-120
Evaluation of a supervised physical activity programme for cancer survivors : from treatment to triathlon
Bron
Journal of rehabilitation medicine : clinical communications - ISSN 2003-0711-3:1 (2020) p. 1-7